Ethics of Gene Editing
By Betty Rollin,
KQED Religion & Ethics Newsweekly
| 07. 02. 2015
[with CGS's Marcy Darnovsky]
<span id="XinhaEditingPostion"></span>
A promising new medical technology has the potential to cure many genetic diseases by deleting or replacing defective genes. But ethicist Marcy Darnovsky of the Center for Genetics and Society is concerned about the safety of the technology, the unintended consequences of gene alteration for future generations, and the possibility of wealthy parents using the technology to “enhance” their children, regardless of medical necessity.
Image via WikiMedia Commons.
Related Articles
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...
By Steve Rose, The Guardian | 01.28.2026
Ed Zitron, EZPR.com; Experience Summit stage;
Web Summit 2024 via Wikipedia Commons licensed under CC by 2.0
If some time in an entirely possible future they come to make a movie about “how the AI bubble burst”, Ed Zitron will...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...